Paratek Pharmaceuticals, Inc — Federal Contractor Profile
Paratek Pharmaceuticals Secures Single $265 Million Contract
Contractor Overview
Total Contract Value: $7,163,538,102 ($7.2B)
Total Awards: 27
Company Profile
PARATEK PHARMACEUTICALS, INC. appears to be a highly specialized entity within the federal contracting landscape, focusing on a singular, substantial contract valued at $265.3 million. This indicates a deep, albeit narrow, engagement with government services. The company's core capabilities are likely centered around the specific domain addressed by this large contract, suggesting expertise in a niche area that commands significant government investment. Without further data on multiple contracts or a history of awards, it's challenging to ascertain their broader operational scope or the full range of their technical proficiencies. The relationship with government agencies is difficult to define given the single contract; it's unclear if this represents a primary or sole client, or if it's part of a larger, less visible portfolio. The scale of their government business is defined by this one large award, making it a significant but isolated contribution. The nature of this contract—whether competitive or sole-source—is not detailed here, but a single, large award could suggest a specialized need or a long-standing relationship. Track record and notable projects are limited to this one contract. The contract pattern reveals a strategy of pursuing and securing large-scale, high-value opportunities rather than a diversified approach across multiple smaller engagements. This suggests a focus on significant projects where their specialized expertise is critically needed and highly valued.
Specializations
- Pharmaceutical Research and Development
- Biotechnology Solutions
- Medical Countermeasures
- Advanced Therapeutics
- Life Sciences Innovation
- Government Health Initiatives
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: Unknown
Agency Concentration: Unknown
Growth Trajectory: Unknown
Competitive Position
Given the limited data of a single, large contract, PARATEK PHARMACEUTICALS, INC.'s competitive position is difficult to assess. They may be a niche specialist capable of handling very specific, high-value government needs. Alternatively, this could represent a significant but isolated project for a company with a broader, less publicly visible footprint. Without more contract history, it's impossible to determine if they are a dominant player or one among many in their specialized field.
Value to Taxpayers
Assessing the value PARATEK PHARMACEUTICALS, INC. provides to taxpayers is challenging with only one contract. The substantial value of this single award suggests a critical need or a complex project requiring specialized expertise. However, without information on how this contract was awarded (competitive vs. sole-source) or performance metrics, it's impossible to definitively state whether it represents optimal value. Further investigation into the contract's objectives and outcomes would be necessary for a comprehensive evaluation.
Agency Relationships
The specific government agencies that rely on PARATEK PHARMACEUTICALS, INC. are not identified in the provided data. Given the nature of pharmaceutical and potentially defense-related contracts, agencies like the Department of Health and Human Services (HHS), the Department of Defense (DoD), or agencies involved in biodefense research are potential clients. The reliance on this contractor would depend on the specific purpose of the $265.3 million contract.
Red Flags
- Lack of contract diversity: A single, large contract may indicate a lack of broader market penetration or a reliance on a single, potentially unstable, revenue stream.
Green Flags
- Significant contract award: Securing a $265.3 million contract demonstrates the company's capability to handle large-scale, complex projects.
Key Contracts
The primary government engagement for PARATEK PHARMACEUTICALS, INC. is a single, substantial contract valued at $265,316,226. The specifics of this contract are not detailed, but its significant size suggests it pertains to a critical area of government operations, likely within the pharmaceutical, biotechnology, or advanced medical research sectors. Such large awards often involve extensive research and development, the production of specialized medical supplies, or the implementation of novel therapeutic solutions for government-specific needs, such as public health initiatives or defense-related medical countermeasures. The singular nature of this contract indicates that PARATEK PHARMACEUTICALS, INC. may specialize in a very niche market or possess unique capabilities that are in high demand by a particular government agency. This contract represents the entirety of their publicly visible federal contracting activity, highlighting their capacity to undertake projects of considerable scope and financial magnitude, and suggesting a strategic focus on securing and executing major government opportunities.
Frequently Asked Questions
What does PARATEK PHARMACEUTICALS, INC. do for the government?
Based on the available data, PARATEK PHARMACEUTICALS, INC. is involved in a single, large government contract worth $265.3 million. While the exact nature of the work is not specified, the company name and contract size strongly suggest specialization in areas such as pharmaceutical research and development, biotechnology, advanced medical solutions, or the creation of medical countermeasures. This contract likely represents a significant undertaking for a specific government agency requiring specialized expertise in life sciences or healthcare.
How much taxpayer money does PARATEK PHARMACEUTICALS, INC. receive?
PARATEK PHARMACEUTICALS, INC. has received a total of $265.3 million in government contracts. This entire amount is attributed to a single contract, indicating a substantial but concentrated financial engagement with the federal government. There is no information available regarding the breakdown of this funding across different agencies or the specific allocation within the contract's scope.
Is PARATEK PHARMACEUTICALS, INC. good value for taxpayer money?
It is difficult to assess the value PARATEK PHARMACEUTICALS, INC. provides to taxpayers with the current limited information. The company has secured a very large contract, suggesting it possesses specialized capabilities that the government deems essential. However, without details on the contract's performance, whether it was awarded competitively or through a sole-source process, and the ultimate outcomes achieved, a definitive judgment on value for money cannot be made. Further analysis of contract performance metrics and cost-effectiveness would be required.
How does PARATEK PHARMACEUTICALS, INC. win its contracts?
The provided data only shows one contract for PARATEK PHARMACEUTICALS, INC., making it impossible to determine their typical contract acquisition strategy. It is unknown whether this contract was won through a competitive bidding process or awarded on a sole-source basis due to unique capabilities or specific requirements. A broader analysis of multiple contracts would be needed to identify patterns in their procurement methods.
What agencies use PARATEK PHARMACEUTICALS, INC. most?
The provided data does not specify which government agencies are clients of PARATEK PHARMACEUTICALS, INC. Given the company's likely specialization in pharmaceuticals or biotechnology, potential clients could include agencies like the Department of Health and Human Services (HHS), the Department of Defense (DoD), or agencies focused on research and development. The single large contract suggests a significant relationship with at least one agency, but the identity of that agency is not disclosed.